Medicare

Medicare paid $3.1M for Viagra, other erectile-dysfunction drugs

Despite a ban on funding for sexual or erectile-dysfunction treatments, Medicare improperly paid $3.1 million for the treatments over a two-year period, according to a new internal report. 

Medicare’s prescription drug processing system is designed to reject erectile dysfunction drugs, but the $3.1 million was approved because the program used an incomplete list of such drugs, the Health and Human Services Office of Inspector General wrote.

The Medicare Part D prescription drug program, launched in 2006, excludes payments for a drug “when used for the treatment of sexual or erectile dysfunction, unless such drug were used to treat a condition, other than sexual or erectile dysfunction, for which the drug has been approved by the Food and Drug Administration.”

The $3.1 million in improper payments represented a small fraction of the $133 billion in Part D’s total drug costs in 2007 and 2008. More than $3 million was spent on Viagra alone.

Medicare said it will determine whether it can recover the money from plan sponsors that were paid for the erectile-dysfunction drugs. Since 2009, the agency has used improved internal controls to monitor drug data, Medicare said.

Tags
See all Hill.TV See all Video

Most Popular

Load more

Video

See all Video